Reduced frequency of melanoma in 72,739 patients with psoriasis

A retrospective study

Andrea Paradisi, Stefano Tabolli, Biagio Didona, Luciano Sobrino, Nicoletta Russo, Damiano Abeni

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background: Chronic inflammatory conditions such as psoriasis may pose an increased risk of cancer due to impaired immunosurveillance resulting from the chronic inflammation and immunosuppressive medications. However, the relationship between psoriasis and the risk of melanoma is still controversial. Objective: To compare the occurrence of melanoma in a cohort of 72,739 psoriasis patients and in 25,956 non-dermatological patients. Methods: A record-linkage was performed between records of hospitalizations and access to day-hospital and day-surgery clinics and outpatient clinics. The frequency of melanoma was compared between psoriasis patients and vascular surgery patients. Occurrence of melanoma was compared by computing the relative risk (RR) and modelled using multiple logistic regression. Results: Overall, occurrence of melanoma was 1.8% (95% CI 1.5-2.2%) in psoriasis patients and 4.5% (95% CI 3.8-5.4%) in non-dermatological patients (RR = 0.40, 95% CI 0.31-0.51). The simultaneous adjustment for gender, age, and phototherapy yielded a RRadj = 0.54(95% CI 0.41-0.70. For patients who underwent phototherapy, vs. those who did not, the RRadj was 1.50 (95% CI 0.56-4.15). Conclusions: In this large retrospective study, patients with psoriasis had a significantly lower probability of having melanoma when compared to a group of non-dermatological patients. Further studies, preferably with a concurrent longitudinal design to estimate incidence with more complete information, are needed to corroborate our findings.

Original languageEnglish
Pages (from-to)133-137
Number of pages5
JournalEuropean Journal of Dermatology
Volume25
Issue number2
DOIs
Publication statusPublished - 2015

Fingerprint

Psoriasis
Melanoma
Retrospective Studies
Phototherapy
Immunologic Monitoring
Immunosuppressive Agents
Ambulatory Care Facilities
Ambulatory Surgical Procedures
Blood Vessels
Hospitalization
Logistic Models
Inflammation
Incidence

Keywords

  • Epidemiology
  • Melanoma
  • Psoriasis
  • Risk

ASJC Scopus subject areas

  • Dermatology

Cite this

Reduced frequency of melanoma in 72,739 patients with psoriasis : A retrospective study. / Paradisi, Andrea; Tabolli, Stefano; Didona, Biagio; Sobrino, Luciano; Russo, Nicoletta; Abeni, Damiano.

In: European Journal of Dermatology, Vol. 25, No. 2, 2015, p. 133-137.

Research output: Contribution to journalArticle

Paradisi, Andrea ; Tabolli, Stefano ; Didona, Biagio ; Sobrino, Luciano ; Russo, Nicoletta ; Abeni, Damiano. / Reduced frequency of melanoma in 72,739 patients with psoriasis : A retrospective study. In: European Journal of Dermatology. 2015 ; Vol. 25, No. 2. pp. 133-137.
@article{d3755ec204db486e945a45d48800e28a,
title = "Reduced frequency of melanoma in 72,739 patients with psoriasis: A retrospective study",
abstract = "Background: Chronic inflammatory conditions such as psoriasis may pose an increased risk of cancer due to impaired immunosurveillance resulting from the chronic inflammation and immunosuppressive medications. However, the relationship between psoriasis and the risk of melanoma is still controversial. Objective: To compare the occurrence of melanoma in a cohort of 72,739 psoriasis patients and in 25,956 non-dermatological patients. Methods: A record-linkage was performed between records of hospitalizations and access to day-hospital and day-surgery clinics and outpatient clinics. The frequency of melanoma was compared between psoriasis patients and vascular surgery patients. Occurrence of melanoma was compared by computing the relative risk (RR) and modelled using multiple logistic regression. Results: Overall, occurrence of melanoma was 1.8{\%} (95{\%} CI 1.5-2.2{\%}) in psoriasis patients and 4.5{\%} (95{\%} CI 3.8-5.4{\%}) in non-dermatological patients (RR = 0.40, 95{\%} CI 0.31-0.51). The simultaneous adjustment for gender, age, and phototherapy yielded a RRadj = 0.54(95{\%} CI 0.41-0.70. For patients who underwent phototherapy, vs. those who did not, the RRadj was 1.50 (95{\%} CI 0.56-4.15). Conclusions: In this large retrospective study, patients with psoriasis had a significantly lower probability of having melanoma when compared to a group of non-dermatological patients. Further studies, preferably with a concurrent longitudinal design to estimate incidence with more complete information, are needed to corroborate our findings.",
keywords = "Epidemiology, Melanoma, Psoriasis, Risk",
author = "Andrea Paradisi and Stefano Tabolli and Biagio Didona and Luciano Sobrino and Nicoletta Russo and Damiano Abeni",
year = "2015",
doi = "10.1684/ejd.2014.2501",
language = "English",
volume = "25",
pages = "133--137",
journal = "European Journal of Dermatology",
issn = "1167-1122",
publisher = "NLM (Medline)",
number = "2",

}

TY - JOUR

T1 - Reduced frequency of melanoma in 72,739 patients with psoriasis

T2 - A retrospective study

AU - Paradisi, Andrea

AU - Tabolli, Stefano

AU - Didona, Biagio

AU - Sobrino, Luciano

AU - Russo, Nicoletta

AU - Abeni, Damiano

PY - 2015

Y1 - 2015

N2 - Background: Chronic inflammatory conditions such as psoriasis may pose an increased risk of cancer due to impaired immunosurveillance resulting from the chronic inflammation and immunosuppressive medications. However, the relationship between psoriasis and the risk of melanoma is still controversial. Objective: To compare the occurrence of melanoma in a cohort of 72,739 psoriasis patients and in 25,956 non-dermatological patients. Methods: A record-linkage was performed between records of hospitalizations and access to day-hospital and day-surgery clinics and outpatient clinics. The frequency of melanoma was compared between psoriasis patients and vascular surgery patients. Occurrence of melanoma was compared by computing the relative risk (RR) and modelled using multiple logistic regression. Results: Overall, occurrence of melanoma was 1.8% (95% CI 1.5-2.2%) in psoriasis patients and 4.5% (95% CI 3.8-5.4%) in non-dermatological patients (RR = 0.40, 95% CI 0.31-0.51). The simultaneous adjustment for gender, age, and phototherapy yielded a RRadj = 0.54(95% CI 0.41-0.70. For patients who underwent phototherapy, vs. those who did not, the RRadj was 1.50 (95% CI 0.56-4.15). Conclusions: In this large retrospective study, patients with psoriasis had a significantly lower probability of having melanoma when compared to a group of non-dermatological patients. Further studies, preferably with a concurrent longitudinal design to estimate incidence with more complete information, are needed to corroborate our findings.

AB - Background: Chronic inflammatory conditions such as psoriasis may pose an increased risk of cancer due to impaired immunosurveillance resulting from the chronic inflammation and immunosuppressive medications. However, the relationship between psoriasis and the risk of melanoma is still controversial. Objective: To compare the occurrence of melanoma in a cohort of 72,739 psoriasis patients and in 25,956 non-dermatological patients. Methods: A record-linkage was performed between records of hospitalizations and access to day-hospital and day-surgery clinics and outpatient clinics. The frequency of melanoma was compared between psoriasis patients and vascular surgery patients. Occurrence of melanoma was compared by computing the relative risk (RR) and modelled using multiple logistic regression. Results: Overall, occurrence of melanoma was 1.8% (95% CI 1.5-2.2%) in psoriasis patients and 4.5% (95% CI 3.8-5.4%) in non-dermatological patients (RR = 0.40, 95% CI 0.31-0.51). The simultaneous adjustment for gender, age, and phototherapy yielded a RRadj = 0.54(95% CI 0.41-0.70. For patients who underwent phototherapy, vs. those who did not, the RRadj was 1.50 (95% CI 0.56-4.15). Conclusions: In this large retrospective study, patients with psoriasis had a significantly lower probability of having melanoma when compared to a group of non-dermatological patients. Further studies, preferably with a concurrent longitudinal design to estimate incidence with more complete information, are needed to corroborate our findings.

KW - Epidemiology

KW - Melanoma

KW - Psoriasis

KW - Risk

UR - http://www.scopus.com/inward/record.url?scp=84931475262&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84931475262&partnerID=8YFLogxK

U2 - 10.1684/ejd.2014.2501

DO - 10.1684/ejd.2014.2501

M3 - Article

VL - 25

SP - 133

EP - 137

JO - European Journal of Dermatology

JF - European Journal of Dermatology

SN - 1167-1122

IS - 2

ER -